Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Agilebiotics Logo
Agilebiotics Growth Score
81
CB Rank
721854
Heat Score
66
AGILeBiotics is an early-stage pharmaceutical company focusing on the development of novel antibiotics.
Founded
obfuscation
PrivateSeed Groningen, Groningen, The Netherlands1-10 www.agilebiotics.com/
Biotechnology
Health Care
Therapeutics
Overview

Agilebiotics
Growth Score
81
Heat Score
66

Growth Score81
-4 pts
in past quarter
Heat Score 66
-1 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Agilebiotics

CB Rank
721854
AGILeBiotics is an early-stage pharmaceutical company focusing on the development of novel antibiotics.
Founded
obfuscation
PrivateSeed Groningen, Groningen, The Netherlands1-10 www.agilebiotics.com/
Biotechnology
Health Care
Therapeutics

Funding Rounds

Seed
OBF
in
obfuscation

Details

Legal Name AGILeBiotics B.V.
Operating Status Active
Company Type For Profit
About the Company
AGILeBiotics is an early-stage pharmaceutical company focusing on the development of novel antibiotics.We are passionately translating innovation into novel antibacterials to treat patients infected by life-threatening hospital-acquired multidrug-resistant infections.
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Toframicin
A semi-synthetic aminoglycoside antibiotic candidate with broad-spectrum activity against priority pathogens, developed for treating serious infections like hospital-acquired pneumonia and bloodstream infections.
ModiDirect Technology
A proprietary scalable chemical reaction technology that enables structural modification of natural product-based antibiotics to develop next-generation antibiotics against multidrug-resistant bacteria.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - Agilebiotics Logo
Seed Round - Agilebiotics
2
obfuscation
— Seed
obfuscation
Seed Round - Agilebiotics Logo
Seed Round - Agilebiotics
2
obfuscation
— Seed
obfuscation
Seed Round - Agilebiotics Logo
Seed Round - Agilebiotics
2
obfuscation
— Seed
obfuscation
Seed Round - Agilebiotics Logo
Seed Round - Agilebiotics
2
obfuscation
— Seed
obfuscation
Seed Round - Agilebiotics Logo
Seed Round - Agilebiotics
2
obfuscation
— Seed

Funding Rounds

Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - Agilebiotics Logo
Seed Round - Agilebiotics
2
obfuscation
— Seed
obfuscation
Seed Round - Agilebiotics Logo
Seed Round - Agilebiotics
2
obfuscation
— Seed
obfuscation
Seed Round - Agilebiotics Logo
Seed Round - Agilebiotics
2
obfuscation
— Seed
obfuscation
Seed Round - Agilebiotics Logo
Seed Round - Agilebiotics
2
obfuscation
— Seed
obfuscation
Seed Round - Agilebiotics Logo
Seed Round - Agilebiotics
2
obfuscation
— Seed

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
RUG Holding Logo
RUG Holding
—
Seed Round - Agilebiotics Logo
Seed Round - Agilebiotics
—
RUG Holding Logo
RUG Holding
—
Seed Round - Agilebiotics Logo
Seed Round - Agilebiotics
—
RUG Holding Logo
RUG Holding
—
Seed Round - Agilebiotics Logo
Seed Round - Agilebiotics
—
RUG Holding Logo
RUG Holding
—
Seed Round - Agilebiotics Logo
Seed Round - Agilebiotics
—
RUG Holding Logo
RUG Holding
—
Seed Round - Agilebiotics Logo
Seed Round - Agilebiotics
—
Market Intelligence
People
View Profiles & Contacts
Headcount 1-10
News
Technology
View Tech Report

Active Website Tech Count

4Agilebiotics is actively using 4 technologies for its website, according to BuiltWith. These include CommonCrawl Top 50m, Gravatar Profiles, and  Common Name Invalid.

Total IP

1Agilebiotics has 1 registered patent in the 'Organic Chemistry' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Agilebiotics's headquarters? Agilebiotics is located in Groningen, Groningen, The Netherlands.Who invested in Agilebiotics? Agilebiotics has 2 investors including RUG Holding and  GJ Smid Fonds.When was the last funding round for Agilebiotics? Agilebiotics closed its last funding round on
obfuscation
from a Seed round.Who are Agilebiotics's competitors? Alternatives and possible competitors to Agilebiotics may include Pfizer, Aurobindo Pharma, and  Spero Therapeutics.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(8fe006b 1)
|